http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 17:13:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/SL+Science+Holding+Limited+Reports+Full+Year+2025+Financial+Results/26667226.html <p><strong>Taipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) -- </strong> SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.</p> <p><strong>Management Commentary</strong></p> <p>&quot;2025 was a highly transformative and foundational year for SL Science as we aggressively advanced our core cell therapy pipeline and executed our long-term strategic shift toward next-generation immunotherapies. Throughout the past year, we strategically prioritized our resources on high-value clinical research and development, committing over $2.07 million to expand http://www.streetinsider.com/Press+Releases/SL+Science+Holding+Limited+Reports+Full+Year+2025+Financial+Results/26667226.html Thu, 18 Jun 2026 17:13:00 -0400 SLBT http://www.streetinsider.com/Globe+Newswire/SL+Science+Holding+Limited+Reports+Full+Year+2025+Financial+Results/26667226.html <p><strong>Taipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) -- </strong> SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.</p> <p><strong>Management Commentary</strong></p> <p>&quot;2025 was a highly transformative and foundational year for SL Science as we aggressively advanced our core cell therapy pipeline and executed our long-term strategic shift toward next-generation immunotherapies. Throughout the past year, we strategically prioritized our resources on high-value clinical research and development, committing over $2.07 million to expand http://www.streetinsider.com/Globe+Newswire/SL+Science+Holding+Limited+Reports+Full+Year+2025+Financial+Results/26667226.html Thu, 18 Jun 2026 17:13:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++SL+Science+Holding+Ltd+++++++++++++++++Filed+by%3A+Wang+Ching-Dong/26666748.html si-local-file:///var/storage/secattach/20260618/26666748.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++SL+Science+Holding+Ltd+++++++++++++++++Filed+by%3A+Wang+Ching-Dong/26666748.html Thu, 18 Jun 2026 16:41:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Wang+Ching-Dong/26666742.html si-local-file:///var/storage/secattach/20260618/26666742.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Wang+Ching-Dong/26666742.html Thu, 18 Jun 2026 16:40:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++SL+Science+Holding+Ltd++++For%3A+Jun+12/26666586.html si-local-file:///var/storage/secattach/20260618/26666586.html http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++SL+Science+Holding+Ltd++++For%3A+Jun+12/26666586.html Thu, 18 Jun 2026 16:31:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Xu+Qian/26658457.html si-local-file:///var/storage/secattach/20260617/26658457.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Xu+Qian/26658457.html Wed, 17 Jun 2026 11:10:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+LAU+JOHNSON+SHUN-PONG/26655289.html si-local-file:///var/storage/secattach/20260616/26655289.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+LAU+JOHNSON+SHUN-PONG/26655289.html Tue, 16 Jun 2026 17:20:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Shen+Ethan+PhD/26655269.html si-local-file:///var/storage/secattach/20260616/26655269.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Shen+Ethan+PhD/26655269.html Tue, 16 Jun 2026 17:19:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Liu+Mingche/26655260.html si-local-file:///var/storage/secattach/20260616/26655260.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Liu+Mingche/26655260.html Tue, 16 Jun 2026 17:17:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Chen+Kwo-Liang/26655243.html si-local-file:///var/storage/secattach/20260616/26655243.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Chen+Kwo-Liang/26655243.html Tue, 16 Jun 2026 17:15:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+General+John+Conrad/26655224.html si-local-file:///var/storage/secattach/20260616/26655224.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+General+John+Conrad/26655224.html Tue, 16 Jun 2026 17:14:00 -0400 SLBT http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Leung+Lok+Sang/26655190.html si-local-file:///var/storage/secattach/20260616/26655190.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++SL+Science+Holding+Ltd++++For%3A+Jun+12++Filed+by%3A+Leung+Lok+Sang/26655190.html Tue, 16 Jun 2026 17:10:00 -0400 SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Press+Releases/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html <p>DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=QpA13qSu6Ts4LTx3QALZDvcIHzeBZ1_2VSIQRxatNmnltgDYaH1KdZcrOXgZbDJlnqDslZJG5Xgxg6jptjDGy-6z9y0jsk2TogpyPNW2h_I=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell therapy expansion to neurodegenerative disease programs and cardiovascular breakthroughs, investors were presented with a wave of catalysts that are driving enthusiasm across several emerging healthcare names. Traders appeared particularly focused on companies advancing toward late-stage clinical development, securing new regulatory clearances, or gaining broader visibility through public market events.</p> <p><em>Download the 24/7 Market News App here </em><a href="https://www.globenewswire.com/Tracker?data=5FeORDTgwZe0oow6VfCQtL1968_KdCj5TiM5vfM3tIc21XaDUfpS7KQzxcqWrRWdfhCBu8lLg57z75nPx_8pSVguk_g7RHr89lLhMrzLL-I=" rel="nofollow" target="_blank"><em><u>https://app.247mnn.com/</u></em></a><em> or on the App Store</em></p> <p>Among http://www.streetinsider.com/Globe+Newswire/Biotech+Bulls+Stampede+as+Clinical+Wins+and+Milestones+Fuel+Momentum/26652208.html Tue, 16 Jun 2026 10:18:28 -0400 CRVO CRVO EWTX EWTX NTHI NTHI SLBT SLBT